The sixty-year-old woman, surnamed Guo, received a three-year sentence for soliciting 1.5 million yuan (USD 216,000) in bribes from five Chinese vaccine companies, according to a ruling from the Number One Beijing Intermediate People's Court.
She is the wife of a former employee of the Chinese Food and Drug Administration, who the court documents said was complicit in the scheme.
Guo was taken into custody in April 2015 and charged with accepting bribes in relation to four biotech firms' efforts to obtain government permits for a variety of vaccines, including those for SARS and avian flu.
The sentence follows the March revelation of a massive vaccine scandal that enraged the Chinese public.
The case involved the improper storage, transport and sale of tens of millions of dollars' worth of vaccines -- many of them expired.
No one was believed to have been harmed, but the story still provoked outrage in a country where families, who were long limited to one child by government policy, fiercely protect their offspring.
Public fury erupted in March after a report revealed that information about the case had been suppressed by authorities who had arrested two key suspects nearly a year earlier.
They included shots for polio, rabies, hepatitis B and flu for both children and adults, Caijing magazine said, citing drug safety officials.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
